date:Sep 24, 2013
significant capabilities for identifying novel genes to combat the variety of acute biotic stresses affecting the worlds key crops.
Under both the original agreement and the extension, Evogene is entitled to receive research payments, success-based milestone payments and future royalty payments based on the sale of resulting products by Syngenta.